Elmind Capital manages investments for private funds through a master feeder structure. The firm focuses on generating attractive risk-adjusted returns using a long/short equity strategy primarily in the small and medium-sized biotech sector. Elmind Capital employs a deep fundamental, bottom-up research approach, primarily focused on North America. The firm may allocate up to 10% of fund assets to illiquid investments.
Fee Structure
Elmind Capital manages investments for private funds and receives asset-based management fees from the Master Fund. There are two classes of investor interests, each subject to a management fee: 1.5% per year for Founders Share Interests and 2.0% per year for Class B Interests, based on the net asset value of each capital account. The management fee is paid quarterly in advance. Elmind Capital may reduce or waive the management fee for certain investors, including employees and affiliates.